Human herpesvirus 8 genoprevalence in populations at disparate risks of Kaposi's sarcoma.
The prevalence of human herpesvirus 8 (HHV-8) in populations at different risks of developing Kaposi's sarcoma (KS) was assessed using a protocol involving immunomagnetic fractionation of CD45+ blood cells prior to detection of the HHV-8 genome by nested PCR. Preliminary studies using blood of eight gay men infected by human immunodeficiency virus-1 (HIV-1) revealed that, for the detection of HHV-8 DNA derived from open reading frame (ORF) 26 of the HHV-8 genome, this protocol provided substantially higher rates (100%) compared to one involving red blood cell (RBC) lysis (0%) and to another requiring double density gradient centrifugation (DDGC) of leukocytes (13%). When the CD45+ fractionation protocol was applied to samples from 103 other HIV-1-infected patients (the vast majority of whom were gay men) and 100 blood donors, the ORF 26 DNA detection rates obtained were 37% and 8%, respectively. When DNA from the variable region 1 of ORF K1 was additionally amplified from samples of the blood donors, a detection rate of 9% was achieved. This rate was highly concordant with the ORF 26 DNA detection rate. Furthermore, the ORF K1 sequences were predominantly unique, assignable to genotypes A1, A4, and C3. When assays for anti-HHV-8 and anti-herpes simplex viruses (HSV) 1 and 2 were applied, significant concordances between HHV-8 DNA detection rates and those relating to anti-HHV-8 and to anti-HSV 1 and 2 were more frequently observed for HIV-1-infected patients than for blood donors. The higher-than-expected HHV-8 genoprevalence rate in blood donors requires further confirmation in view of its implications for post-transfusion HHV-8 transmission.
Kumar
Navdeep
N
Oral Medicine and Special Needs, UCL Eastman Dental Institute, University College London, University of London, London, UK. n.kumar@eastman.ucl.ac.uk
McLean
Ken
K
Inoue
Naoki
N
Moles
David R
DR
Scully
Crispian
C
Porter
Stephen R
SR
Teo
Chong Gee
CG
D000163:Acquired Immunodeficiency Syndrome / Q000097:blood / Q000821:virology*; D004279:DNA, Viral / Q000235:genetics; D019288:Herpesvirus 8, Human / Q000235:genetics / Q000302:isolation & purification*; D006801:Humans; D015995:Prevalence; D012044:Regression Analysis; D012514:Sarcoma, Kaposi / Q000097:blood / Q000453:epidemiology* / Q000473:pathology / Q000821:virology*
D004279:DNA, Viral